Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
I'm LongbridgeAI, I can summarize articles.Veea shares surged 58.1% premarket following a merger term sheet with NovaGen and a $10M investment from GeoNova. Other notable movers include Biodexa Pharmaceuticals (+101.8%), My Size Inc (+68.1%), and Advasa Holdings (+50.6%). On the downside, Intercont tumbled 34.9% due to a reverse split, while Scinai Immunotherapeutics (-22.5%) and Future Fintech Group (-21.5%) also saw significant declines.
Shares of Veea Inc (NASDAQ:VEEA) rose sharply in pre-market trading after the company announced a potential merger with NovaGen Group B.V. and a $10 million cornerstone investment from GeoNova Capital.
Veea and NovaGen signed a term sheet to combine and are targeting execution of a definitive business combination agreement within the coming weeks.
Veea shares jumped 58.1% to $3.62 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) gained 101.8% to $2.26 in pre-market trading. Biodexa Pharmaceuticals shares dropped around 14% on Monday after the company announced interim results for the six months ended June 30, 2026.
- My Size Inc (NASDAQ:MYSZ) gained 68.1% to $2.79 in pre-market trading after the company announced an acquisition-led strategy focused on building a defense technology platform.
- Advasa Holdings (NASDAQ:ADBT) rose 50.6% to $0.15 in pre-market trading after dipping around 58% on Monday.
- Silexion Therapeutics Corp (NASDAQ:SLXN) gained 32.3% to $0.51 in pre-market trading after gaining 8% on Monday.
- Smart Logistics Global Ltd (NASDAQ:SLGB) rose 20.1% to $0.41 in pre-market trading after dropping 7% on Monday.
- Mingteng International Corp Inc (NASDAQ:MTEN) rose 15% to $1.16 in pre-market trading.
- Radiant Logistics Inc (NYSE:RLGT) gained 13.3% to $9.30 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
- Editas Medicine Inc (NASDAQ:EDIT) gained 9.1% to $2.99 in pre-market trading.
- Entera Bio Ltd (NASDAQ:ENTX) rose 8.5% to $3.06 in pre-market trading
Losers
- Intercont (Cayman) Ltd (NASDAQ:NCT) tumbled 34.9% to $0.33 in pre-market trading after the company announced a 1-for-25 reverse share split, effective Sept. 17.
- Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) fell 22.5% to $1.89 in pre-market trading after gaining 47% on Monday.
- Future Fintech Group Inc (NASDAQ:FTFT) fell 21.5% to $6.31 in pre-market trading after gaining 179% on Monday.
- Enova International Inc (NYSE:ENVA) fell 18% to $186.00 in pre-market trading after the company announced that it has withdrawn its applications related to the proposed acquisition of Grasshopper Bancorp.
- Cellectis SA (NASDAQ:CLLS) fell 14.7% to $1.56 in pre-market trading after dipping 41% on Monday. The company announced its board approved a strategic transformation to become an in vivo gene editing company focused on developing long-lasting treatments for chronic diseases.
- Antelope Enterprise Holdings Ltd (NASDAQ:AEHL) declined 13% to $5.28 in pre-market trading after dipping 22% on Monday. The company recently announced the pricing of a $6 million convertible promissory note to Stratosphere Capital Management.
- Dave and Buster’s Entertainment, Inc (NASDAQ:PLAY) fell 13.7% to $7.31 in pre-market trading after the company posted downbeat second-quarter fiscal 2026 results.
- Q/C Technologies Inc (NASDAQ:QCLS) fell 12.4% to $0.49 in pre-market trading after dropping 67% on Monday. Q/C Technologies terminated consulting agreements with Chelsea Voss and Ocean Avenue Holdings, affiliate of Martin Shkreli.
- Mach Natural Resources LP (NYSE:MNR) fell 10.7% to $11.17 in pre-market trading.
- Kestra Medical Technologies Ltd (NASDAQ:KMTS) fell 8.6% to $21.99 in pre-market trading after the company reported mixed first-quarter financial results.
Photo via Shutterstock